Holmium-166 TARE in Liver Limited Unresectable Colorectal Cancer Patients
Condition(s):Colorectal Cancer MetastaticLast Updated:March 27, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Colorectal Cancer MetastaticLast Updated:March 27, 2024Recruiting
Condition(s):Gastric Cancer; HER2-positive Gastric CancerLast Updated:February 12, 2024Not yet recruiting
Condition(s):Biliary Tract Cancer; CholangiocarcinomaLast Updated:November 15, 2023Recruiting
Condition(s):Colorectal Cancer; Resectable Colorectal CarcinomaLast Updated:September 21, 2023Recruiting
Condition(s):Squamous Cell Carcinoma of Head and NeckLast Updated:April 6, 2023Completed
Condition(s):Merkel Cell CarcinomaLast Updated:January 5, 2023Recruiting
Condition(s):Locally Advanced Rectal CancerLast Updated:March 6, 2024Active, not recruiting
Condition(s):Stage II Colon Cancer; Stage III Colon Cancer; HER2-positive Colon Cancer; RAS Wild-type Colon CancerLast Updated:December 29, 2023Recruiting
Condition(s):Nasopharyngeal CarcinomaLast Updated:April 7, 2022Recruiting
Condition(s):Gastric Cancer; Microsatellite InstabilityLast Updated:October 31, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.